Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. News/
    3. Innovation/
    4. Inside the development of Johnson & Johnson’s OTTAVA™ Robotic Surgical System
    poster.jpg

    Inside the development of Johnson & Johnson’s OTTAVA™ Robotic Surgical System

    Built to expand OR capacity, maintain procedural momentum and elevate performance, OTTAVA™ is opening new possibilities in surgery. Neda Cvijetic, Global Head of Robotics & Digital R&D, MedTech at Johnson & Johnson, explains what surgeons need to know.

    Key takeaways about the OTTAVA™ Robotic Surgical System

    • Johnson & Johnson’s OTTAVA™ Robotic Surgical System was granted market authorization by the U.S. Food & Drug Administration (FDA)1 in July for use in multiple procedures in general surgery within the upper abdomen.
    • With its unique architecture, including robotic arms integrated into the operating table2, OTTAVA™ takes up considerably less space than traditional boom- and cart-mounted systems3* with the potential to create efficiencies across surgical workflows4†.
    • OTTAVA™ is connected to the Polyphonic™ Digital Ecosystem, which connects surgical data, video, devices and data-driven insights to support surgical teams throughout the OTTAVA™ experience5.
    • Developed based on feedback from surgeons, OTTAVA™ is designed as a robotic-assisted platform that supports portions of open, laparoscopic or nonrobotic workflows where consistent with its labeled use6.
    Today’s operating room (OR) is more complex than ever. Surgical case volumes continue to rise and patients undergoing surgery are older, with more comorbidities and medical needs. Surgeons and clinical teams are working with a growing number of devices, which are often disconnected from each other, require additional training to use and may force teams to adapt to them. The future of surgery needs innovations that help surgical teams work with greater efficiency, consistency and confidence.

    Designed around the realities of surgery today, Johnson & Johnson’s OTTAVA™ Robotic Surgical System is built to expand OR capacity, maintain procedural momentum and elevate performance5—supporting teams as they navigate existing infrastructure constraints, case complexities and the need for greater data visibility and flexibility. In July, the FDA authorized OTTAVA™ for use in procedures in the upper abdomen, like gastric bypass, splenectomy, small bowel resection, appendectomy and hiatal hernia repair7.

    Robotic surgery systems are not a new part of the healthcare landscape, but the design of OTTAVA™ creates a new category5. While traditional boom- and cart-mounted robotic surgical systems have a reputation for being cumbersome to set up and work around, OTTAVA™ integrates four robotic arms directly into the operating table, taking up much less space3* and creating workflow efficiencies in the OR 4†.
    Headshot of Neda Cvijetic, Global Head of Robotics & Digital R&D, MedTech at Johnson & Johnson, who led the engineering teams that designed and built OTTAVA™

    Neda Cvijetic, Global Head of Robotics & Digital R&D, MedTech at Johnson & Johnson

    Among its differentiated features are its automation capabilities and the portfolio of surgical instruments, built on proven Ethicon technology5 and reimagined for robotic use5. Connection to Johnson & Johnson’s Polyphonic™ Digital Ecosystem brings learning, media and data-driven insights together in one experience5 and empowers the secure capturing of data that can fuel research and innovation5.

    Neda Cvijetic, Global Head of Robotics & Digital R&D, MedTech, Johnson & Johnson, leads the engineering teams that designed and built OTTAVA™. Before joining the company in 2024, Cvijetic spent over two decades building and scaling transformative AI (artificial intelligence), software and automated robotics systems in the tech and automotive industries.

    Developing OTTAVA™ helped her bring these technologies together into what she calls a “human-centric dimension,” keeping the surgeons, the OR staff and the patient directly at the center of the system and design.

    “OTTAVA™ shows Johnson & Johnson’s commitment to surgeons, care teams and patients, and it delivers on the company’s belief that innovations, especially in robotics, will improve patient outcomes,” says Cvijetic. “This is how the company that invented modern sterile surgery does robotic surgery.”

    Here, Cvijetic explains the state-of-the-art engineering behind OTTAVA™, the benefits it is designed to offer both surgeons and their teams and how this novel robotic system will continue to advance surgical care.

    Q:

    Johnson & Johnson has a long history of listening to the needs of surgeons. What specific feedback from surgeons went into developing and designing OTTAVA™?

    A:

    One way we’ve listened to surgeons is by bringing Ethicon surgical instrumentation onto OTTAVA™. Through Ethicon, we have decades of deep understanding of the science of tissue interactions with instruments, as well as a track record of trusted surgical instrument performance5. Surgeons said they wanted that same trusted instrumentation technology in robotic form, so we’ve built it in.

    Setting up the OR and the devices and technologies required for a procedure can add additional time and complexity to the overall procedure. OTTAVA™ offers unique architecture and automation capabilities, with intelligent robotic arms that can move into a setup pose or a procedure pose with the push of a button5. This feature can support the surgical care team assisting at the bedside by limiting the manual nature and complexity of moving the robotic arms into position and giving the surgeon confidence that their staff can get OTTAVA™ into the right position10**.

    We also learned that surgeons want greater access to data and insights. In the current environment, fully sharing data from a given robotic procedure with surgeons or hospitals is limited.

    So, data-driven insights from OTTAVA™ are designed to be accessible through Johnson & Johnson’s Polyphonic™ Digital Ecosystem. Polyphonic™ is an open, secure system that brings together surgical data, video, devices and AI insights, allowing healthcare teams across different surgical sites to collaborate more effectively5. The ability to share this information is incredibly valuable for learning, and ultimately for improving patient outcomes.

    Through Ethicon, we have decades of deep understanding of the science of tissue interactions with instruments, as well as a track record of trusted surgical performance. Surgeons said they wanted that same trusted instrumentation technology in robotic form, so we’ve built it in.
    Neda Cvijetic
    Global Head of Robotics & Digital R&D, MedTech at Johnson & Johnson

    Q:

    How does the novel architecture of OTTAVA™ address today’s OR, which is crowded with devices, people and movement?

    A:

    Today, the footprint of most robotic systems in terms of size and weight is big, which means that not every OR can be a robotic OR. To bring in a robotics system, hospitals may have to redesign their layouts or reinforce the floor to support all the weight. That can be very challenging and costly.

    Because of its category-defining architecture, with the arms integrated into the table, OTTAVA™ was designed to fit into various OR sizes5***. In our clinical trial results, we found that OTTAVA™ was able to go into operating rooms as small as 243 square feet that were previously considered too small for robotic surgery5***. That’s a game changer.

    What we’ve heard consistently from surgeons, surgical care teams and hospital administrators is the importance of more space in an operating room. OTTAVA™ creates more space for surgical teams to work, coordinate and communicate3.

    Q:

    How many teams were involved in developing OTTAVA™, and what did each team contribute?

    A:

    Several remarkable and dedicated robotics engineering teams have been working to develop OTTAVA™. Mechanical and electrical hardware engineers designed the intelligent robotic arms. Together with systems integration engineers, they integrated them into the table and made sure that the motors and the sensors inside these arms performed correctly.

    Robotics controls and software engineers created the automation algorithms; cloud and data engineers architected OTTAVA™ connectivity and analytics capabilities. Human factors engineers ensured the ergonomics, usability and the natural interface of the system. And clinical engineers made sure that the clinical workflows are effective and streamlined.

    It has taken excellence along all of these dimensions to bring OTTAVA™ to life. I’m so proud of our engineering teams and their commitment. They could bring their extraordinary talent anywhere to any industry and are choosing to use it to elevate surgical care.

    Q:

    OTTAVA™ has been described as having “twin motion” to support patient repositioning and access to the anatomy. How can this and other aspects of its design, such as motorized arms, be beneficial to surgeons?

    A:

    In nonrobotic procedures, surgeons are able to tilt the operating table and use gravity to move anatomy out of the way to gain access in a procedure. This is valuable for the patient because it minimizes potential trauma to tissue.

    In robotic procedures today, they’re not able to do this because the robotic arms and the surgical table don’t move together. You would have to remove surgical instruments, undock, tilt the table, then put everything back.

    OTTAVA™ has table-integrated architecture “twin motion,” which means that the arms and the table move together, in synchrony8, 9. That capability of using gravity that surgeons are used to in a nonrobotic world? Well, we brought that to them in the robotic world.

    Surgeon demonstrating the synchronized "twin motion" arms of the OTTAVA™ Robotic Surgical System, which move together with the operating table for improved tissue access

    The “twin motion” arms of the OTTAVA™ Robotic Surgical System move together with the operating table.

    Q:

    Will OTTAVA™ open up future possibilities for digital systems in surgery? For example, using digital twins and simulation to train surgeons?

    A:

    Unequivocally yes. OTTAVA™ isn’t a fixed-function robot that does the same thing throughout its lifetime. Think about a software update on a car. The update enhances it and allows it to have new capabilities.

    OTTAVA™ was designed the same way. It’s a continuous innovation platform in terms of digital, software, automation and AI functionality5.

    Simulation enables us to create a digital twin of the robot in the virtual world, as well as a digital twin of the entire operating room. The simulation is created with geometric precision, accuracy in lighting, accuracy in the physics of both the robot and other components of the OR. I envision a future in which teams could rehearse a procedure and personalize it for the patient before ever setting foot in an OR.

    And with new simulation techniques, I envision us also being able to simulate surgical scenes inside the human body with high fidelity to help surgeons train and practice situations that perhaps would have taken decades to encounter in real life.

    Q:

    We understand and hear from surgeons that they are being asked to do more. Learning new technologies like AI can both contribute to and alleviate this. Was OTTAVA™ designed with these challenges in mind?

    A:

    We designed OTTAVA™ to address real-world challenges and help transform the surgeon and care team experience.

    OTTAVA™ does this by leveraging advanced AI-based simulation for preoperative planning and training experiences, or by creating and sharing data-driven postoperative insights via Polyphonic™.

    Whether it’s by creating advanced AI-based simulation for preoperative planning and training experiences or by creating and sharing data-driven postoperative insights via Polyphonic™5 , we have designed OTTAVA™ for what’s next in Surgery5.

    References
    *Based on an evaluation of systems available as of September 2025
    †Based on a U.S. survey of surgeons (n=12) and surgical staff (n=8) evaluating their experience with the OTTAVA™ Robotic Surgical System following participation in an IDE clinical trial. Respondents had completed between 1 and 5 Roux-en-Y gastric bypass procedures using OTTAVA™ at the time of survey completion. Survey responses were collected using a 5-point Likert scale; reported results reflect the combined proportion of respondents selecting “Agree” (4) or “Strongly Agree” (5).
    **Data for upper abdominal procedures, from arms stowed to docked
    ***Five of the six operating rooms utilized in the clinical trial were previously non-robotic and included spaces that had been considered too small to accommodate a robotic system. The operating room sizes ranged from 243 sq ft (23 m²) to 694 sq ft (65 m²)
    1 FDA Device Classification. Accessed September 2026
    2 Johnson & Johnson and its affiliates. OTTAVA™ Robotic Surgical System Claims Support Documentation. November 2024
    3 Johnson & Johnson and its affiliates. OTTAVA™ Robotic Surgical System Claims Support Documentation. September 2025
    4 Johnson & Johnson and its affiliates. OTTAVA Forte IDE Surgeon and Staff User Experience. Quantitative Report. April 2026
    5 Johnson & Johnson and its affiliates. OTTAVA Brand Messages. June, 2026
    6 OTTAVA Council VOC Summary. June 2026
    7 OTTAVA Launch Press Release. July 2026
    8 Johnson & Johnson and its affiliates. OTTAVA™ Robotic Surgical System Claims Support Documentation. Nov 2025
    9 Johnson & Johnson and its affiliates. OTTAVA™ Robotic Surgical System Claims Support Memo. Jan 2026
    10 Johnson & Johnson and its affiliates. OTTAVA Procedure Assisted Setup Analysis. August 2026
    © Johnson and Johnson and its affiliates 2026.
    US_SRG_RADS_421236
    For complete indications, contraindications, warnings, precautions and adverse reactions, please
    reference full package insert. The third-party trademarks used herein are trademarks of their respective owners.

    More from Johnson & Johnson